Search

Your search keyword '"Ruvoletto, Mariagrazia"' showing total 157 results

Search Constraints

Start Over You searched for: Author "Ruvoletto, Mariagrazia" Remove constraint Author: "Ruvoletto, Mariagrazia"
157 results on '"Ruvoletto, Mariagrazia"'

Search Results

1. The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis

2. 1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition.

3. SAT-219 Discovering 1-piperidine propionic acid inhibiting effect on protease activated receptor 2 and serpinb3 as a new therapeutic strategy for metabolic dysfunction-associated steatohepatitis

4. Inhibition of Protease-Activated Receptor-2 Activation in Parkinson's Disease Using 1-Piperidin Propionic Acid.

5. The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation

8. The polymorphic variant of SerpinB3 (SerpinB3‐PD) is associated with faster cirrhosis decompensation.

9. Inhibition of CCAT/enhancer-binding protein beta-serpinB3 axis by 1-piperidin propionic acid: a new targeted therapy for non-alcoholic steatohepatitis

10. SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness

14. The CCAAT/Enhancer-Binding Protein Beta - SerpinB3 Axis Inhibition as a Novel Strategy for Non-Alcoholic Steatohepatitis Treatment

16. Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo

18. SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease

20. Engineered EVs for Oxidative Stress Protection

21. Low P66shc with High SerpinB3 Levels Favors Necroptosis and Better Survival in Hepatocellular Carcinoma

22. WED-449 - Inhibition of CCAT/enhancer-binding protein beta-serpinB3 axis by 1-piperidin propionic acid: a new targeted therapy for non-alcoholic steatohepatitis

23. SERPINB3 inhibition as a novel target therapy for non-alcoholic steatohepatitis

29. SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets

30. FRI-117-The gain of function mutation of SerpinB3 (SCCA-PD) is associated with the severity of portal hypertension and complications onset in patients with advanced liver disease

32. SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer

34. SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity

35. CORRIGENDUM: SERPINB3 is associated with longer survival in transgenic mice

36. Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles

37. RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA

43. SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE

47. SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE

Catalog

Books, media, physical & digital resources